Largest health care companies
The 1,025 US-listed companies in the health care sector, ranked by market capitalisation. Sector comes from each company's Nasdaq classification; revenue and earnings come from its SEC filings.
Combined market cap
$9.112 T
9.1% of all US-listed value
Companies
1,025
Ranked #5 of 12 sectors
Average
$8.889 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 1 | Eli Lilly & CoLLY | $1.12T | $1,185.71 | -0.52% | United States |
| 2 | Johnson & JohnsonJNJ | $624.7B | $259.24 | +0.88% | United States |
| 3 | AbbVieABBV | $434.8B | $246.04 | +0.89% | United States |
| 4 | UnitedHealth GroupUNH | $369.7B | $407.08 | +0.77% | United States |
| 5 | Merck & Co.MRK | $317.6B | $128.58 | +0.16% | United States |
| 6 | NovartisNVS | $298.3B | $156.33 | +1.38% | Switzerland |
| 7 | Philip Morris InternationalPM | $295.5B | $189.57 | +0.81% | United States |
| 8 | AstrazenecaAZN | $250.3B | $161.42 | +0.22% | United Kingdom |
| 9 | AmgenAMGN | $222.2B | $410.95 | +1.50% | United States |
| 10 | Novo Nordisk A SNVO | $209.3B | $47.26 | +2.81% | Denmark |
| 11 | Abbott LaboratoriesABT | $186.6B | $107.81 | -0.14% | United States |
| 12 | Gilead SciencesGILD | $165.4B | $133.21 | +1.80% | United States |
| 13 | PfizerPFE | $152.5B | $26.76 | +2.14% | United States |
| 14 | Intuitive SurgicalISRG | $133.8B | $378.81 | +1.36% | United States |
| 15 | Bristol Myers SquibbBMY | $132.2B | $64.72 | +0.89% | United States |
| 16 | StrykerSYK | $130.0B | $339.03 | +0.47% | United States |
| 17 | British American Tobacco p.l.c.BTI | $128.6B | $59.33 | +1.02% | United Kingdom |
| 18 | Vertex Pharmaceuticals Inc / MaVRTX | $125.7B | $496.07 | +2.49% | United States |
| 19 | Altria GroupMO | $114.1B | $68.35 | +0.89% | United States |
| 20 | MedtronicMDT | $111.6B | $87.16 | +1.44% | United States |
| 21 | GSKGSK | $107.3B | $52.96 | +1.51% | United Kingdom |
| 22 | SanofiSNY | $106.0B | $43.46 | +1.33% | France |
| 23 | McKessonMCK | $101.4B | $869.58 | -0.21% | United States |
| 24 | 3MMMM | $94.3B | $182.90 | +1.21% | United States |
| 25 | HCA HealthcareHCA | $89.5B | $413.36 | +1.09% | United States |
| 26 | Elevance HealthELV | $85.5B | $394.20 | +0.71% | United States |
| 27 | Regeneron PharmaceuticalsREGN | $80.8B | $784.36 | +1.59% | United States |
| 28 | Cigna GroupCI | $74.6B | $282.49 | +2.63% | United States |
| 29 | Boston ScientificBSX | $71.5B | $49.31 | +0.02% | United States |
| 30 | CencoraCOR | $61.2B | $320.46 | -1.40% | United States |
| 31 | Cardinal HealthCAH | $55.4B | $236.40 | -0.53% | United States |
| 32 | Takeda PharmaceuticalTAK | $55.1B | $17.45 | +2.53% | Japan |
| 33 | Argenx SeARGX | $53.7B | $865.04 | -1.17% | Netherlands |
| 34 | Edwards LifesciencesEW | $51.7B | $89.72 | +0.45% | United States |
| 35 | Becton Dickinson & CoBDX | $48.7B | $176.86 | -0.12% | United States |
| 36 | MedlineMDLN | $46.3B | $35.23 | +2.09% | United States |
| 37 | HumanaHUM | $46.2B | $385.00 | +4.84% | United States |
| 38 | Idexx LaboratoriesIDXX | $46.2B | $586.67 | -0.56% | United States |
| 39 | NateraNTRA | $46.1B | $322.10 | +21.37% | United States |
| 40 | Revolution MedicinesRVMD | $44.0B | $205.15 | +3.71% | United States |
| 41 | Teva Pharmaceutical IndustriesTEVA | $41.2B | $35.36 | +1.58% | Israel |
| 42 | BeOne MedicinesONC | $39.6B | $348.27 | +5.60% | Cayman Islands |
| 43 | IqviaIQV | $39.3B | $238.70 | +2.70% | United States |
| 44 | AlconALC | $35.9B | $71.81 | +3.26% | Switzerland |
| 45 | Royalty PharmaRPRX | $32.6B | $56.77 | -0.86% | United States |
| 46 | CenteneCNC | $32.5B | $65.77 | +2.44% | United States |
| 47 | GE HealthCare TechnologiesGEHC | $32.4B | $71.77 | +2.08% | United States |
| 48 | DexcomDXCM | $32.0B | $84.75 | +2.08% | United States |
| 49 | ResmedRMD | $30.7B | $211.94 | -5.06% | United States |
| 50 | BiogenBIIB | $30.7B | $207.94 | +0.80% | United States |
| 51 | ZoetisZTS | $30.5B | $72.66 | -5.97% | United States |
| 52 | Alnylam PharmaceuticalsALNY | $29.3B | $219.20 | +1.43% | United States |
| 53 | InsmedINSM | $28.4B | $131.10 | -1.09% | United States |
| 54 | IlluminaILMN | $28.4B | $187.96 | -2.97% | United States |
| 55 | Quest DiagnosticsDGX | $26.3B | $238.35 | -0.06% | United States |
| 56 | Koninklijke PhilipsPHG | $26.3B | $26.73 | +1.52% | Netherlands |
| 57 | Roivant SciencesROIV | $26.3B | $36.34 | +3.47% | United Kingdom |
| 58 | LabcorpLH | $25.9B | $319.17 | +0.83% | United States |
| 59 | West Pharmaceutical ServicesWST | $24.9B | $354.07 | +1.57% | United States |
| 60 | IncyteINCY | $24.4B | $120.56 | +1.84% | United States |
| 61 | ModernaMRNA | $23.6B | $59.17 | +9.86% | United States |
| 62 | BioNTech SEBNTX | $23.5B | $93.67 | +2.72% | Germany |
| 63 | STERISSTE | $23.2B | $237.47 | +2.46% | United States |
| 64 | United TherapeuticsUTHR | $23.1B | $538.84 | +1.11% | United States |
| 65 | Guardant HealthGH | $22.6B | $168.48 | +6.92% | United States |
| 66 | Tenet HealthcareTHC | $21.1B | $262.13 | +2.14% | United States |
| 67 | ViatrisVTRS | $19.1B | $16.43 | +0.86% | United States |
| 68 | Zimmer BiometZBH | $18.4B | $96.55 | -0.66% | United States |
| 69 | Jazz PharmaceuticalsJAZZ | $16.7B | $256.56 | -0.04% | Ireland |
| 70 | Neurocrine BiosciencesNBIX | $16.6B | $163.41 | +2.25% | United States |
| 71 | BridgeBio PharmaBBIO | $16.5B | $84.48 | +2.03% | United States |
| 72 | MedpaceMEDP | $16.5B | $590.67 | +0.97% | United States |
| 73 | Ascendis Pharma A/SASND | $15.8B | $255.41 | +2.23% | Denmark |
| 74 | UL SolutionsULS | $15.8B | $78.21 | +1.76% | United States |
| 75 | Cooper CompaniesCOO | $14.5B | $74.23 | +1.24% | United States |
| 76 | Baxter InternationalBAX | $14.2B | $27.55 | +2.00% | United States |
| 77 | SolventumSOLV | $14.1B | $82.98 | +0.02% | United States |
| 78 | Fresenius Medical CareFMS | $13.6B | $24.27 | +0.70% | Germany |
| 79 | ExelixisEXEL | $13.4B | $54.07 | +3.58% | United States |
| 80 | Smith & NephewSNN | $12.8B | $30.11 | +1.42% | United Kingdom |
| 81 | PenumbraPEN | $12.8B | $324.66 | -0.06% | United States |
| 82 | Charles River Laboratories InternationalCRL | $12.8B | $267.49 | +0.75% | United States |
| 83 | IconICLR | $12.6B | $164.51 | +2.07% | Ireland |
| 84 | Encompass HealthEHC | $12.4B | $125.23 | +0.33% | United States |
| 85 | Arrowhead PharmaceuticalsARWR | $12.4B | $87.65 | +2.12% | United States |
| 86 | BrightSpring Health ServicesBTSG | $12.4B | $62.43 | +3.02% | United States |
| 87 | Align TechnologyALGN | $12.3B | $173.66 | +2.71% | United States |
| 88 | Biomarin PharmaceuticalBMRN | $12.3B | $63.81 | +3.82% | United States |
| 89 | Halozyme TherapeuticsHALO | $12.2B | $103.12 | +20.24% | United States |
| 90 | Corcept TherapeuticsCORT | $12.0B | $110.77 | +2.61% | United States |
| 91 | Madrigal PharmaceuticalsMDGL | $11.8B | $510.04 | -0.06% | United States |
| 92 | DavitaDVA | $11.7B | $183.77 | +1.72% | United States |
| 93 | Bio-TechneTECH | $11.3B | $72.29 | +0.54% | United States |
| 94 | AbivaxABVX | $11.3B | $130.93 | +0.71% | France |
| 95 | Globus MedicalGMED | $11.2B | $82.35 | +1.57% | United States |
| 96 | Summit TherapeuticsSMMT | $11.1B | $13.96 | +3.10% | United States |
| 97 | Elanco Animal HealthELAN | $11.1B | $22.12 | -8.60% | United States |
| 98 | Axsome TherapeuticsAXSM | $10.9B | $212.74 | +1.24% | United States |
| 99 | Ensign GroupENSG | $10.7B | $182.97 | +0.72% | United States |
| 100 | GlaukosGKOS | $10.6B | $180.02 | +5.28% | United States |
Showing the largest 100 of 1,025 companies. One row per company โ secondary share classes are folded into their primary listing. Updated 9 Aug 2026.
Industries in Health Care
Biotechnology: Pharmaceutical Preparations 501Medical Specialities 43Biotechnology: Biological Products (No Diagnostic Substances) 160Medical/Dental Instruments 124Medicinal Chemicals and Botanical Products 26Industrial Specialties 30Other Pharmaceuticals 11Hospital/Nursing Management 14Biotechnology: Electromedical & Electrotherapeutic Apparatus 28Biotechnology: Commercial Physical & Biological Resarch 12Biotechnology: In Vitro & In Vivo Diagnostic Substances 19Ophthalmic Goods 8Medical Electronics 5Medical/Nursing Services 29Misc Health and Biotechnology Services 10Precision Instruments 3Pharmaceuticals and Biotechnology 1Managed Health Care 1
Other sectors
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered โ see methodology.